Eli Lilly | SCHULD



Debt Veränderung Datum
AbbVie USD 69.89B 2.74B 2025-03
Abbott USD 13.44B 195M 2025-06
ALKERMES USD 72.68M 72.68M 2025-06
Amgen USD 56.2B 1.18B 2025-06
AstraZeneca USD 32.84B 1.19B 2025-06
Baxter International USD 10.31B 2.82B 2025-03
Biogen USD 6.59B 296.8M 2025-06
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Drreddys Laboratories INR 51.08B 2.55B 2024-12
Eli Lilly USD 39.9B 1.39B 2025-06
Gilead Sciences USD 24.95B 6M 2025-06
GlaxoSmithKline GBP 17.35B 1.08B 2025-06
Glaxosmithkline GBP 16.99B 927M 2024-12
J&J USD 52.25B 15.62B 2025-03
Medtronic USD 28.52B 1.91B 2025-04
Merck USD 34.84B 2.27B 2025-03
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Novartis USD 31.27B 12M 2025-03
Novartis USD 31.26B 828M 2024-12
Novo Nordisk 118.72B 61.75B 2025-03
Perrigo USD 3.65B 24.4M 2025-06
Pfizer USD 60.93B 1.18B 2025-06
Prestige Brands USD 1.04B 27.25M 2025-06
Regeneron Pharmaceuticals USD 2.71B 300K 2025-06
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 22.28B 1.24B 2025-06
Sanofi 17.91B 5.85B 2024-12
United Therapeutics USD 200M 100M 2025-03
Zoetis USD 6.79B 214M 2025-06


Eli Lilly SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.